RU2007101531A - Субъединичная вакцина против prrsv - Google Patents

Субъединичная вакцина против prrsv Download PDF

Info

Publication number
RU2007101531A
RU2007101531A RU2007101531/13A RU2007101531A RU2007101531A RU 2007101531 A RU2007101531 A RU 2007101531A RU 2007101531/13 A RU2007101531/13 A RU 2007101531/13A RU 2007101531 A RU2007101531 A RU 2007101531A RU 2007101531 A RU2007101531 A RU 2007101531A
Authority
RU
Russia
Prior art keywords
prrsv
orf1
consecutive
combinations
group
Prior art date
Application number
RU2007101531/13A
Other languages
English (en)
Russian (ru)
Inventor
Эрик М. ВОН (US)
Эрик М. ВОН
Ричард СТАММЕР (US)
Ричард СТАММЕР
Original Assignee
Берингер Ингельгейм Ветмедика, Инк. (Us)
Берингер Ингельгейм Ветмедика, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельгейм Ветмедика, Инк. (Us), Берингер Ингельгейм Ветмедика, Инк. filed Critical Берингер Ингельгейм Ветмедика, Инк. (Us)
Publication of RU2007101531A publication Critical patent/RU2007101531A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2007101531/13A 2004-06-17 2005-06-17 Субъединичная вакцина против prrsv RU2007101531A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58135004P 2004-06-17 2004-06-17
US60/581,350 2004-06-17
US11/154,617 2005-06-16
US11/154,617 US7722878B2 (en) 2004-06-17 2005-06-16 PRRSV subunit vaccines

Publications (1)

Publication Number Publication Date
RU2007101531A true RU2007101531A (ru) 2008-07-27

Family

ID=35431312

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007101531/13A RU2007101531A (ru) 2004-06-17 2005-06-17 Субъединичная вакцина против prrsv

Country Status (14)

Country Link
US (1) US7722878B2 (enExample)
EP (1) EP1755664B1 (enExample)
JP (1) JP2008503221A (enExample)
KR (1) KR20070028431A (enExample)
AR (1) AR049825A1 (enExample)
AU (1) AU2005258092A1 (enExample)
BR (1) BRPI0510930A (enExample)
CA (1) CA2570778A1 (enExample)
DK (1) DK1755664T3 (enExample)
ES (1) ES2546933T3 (enExample)
MX (1) MXPA06014821A (enExample)
RU (1) RU2007101531A (enExample)
TW (1) TW200603825A (enExample)
WO (1) WO2006002193A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP1157121B1 (en) 1999-03-08 2013-04-24 Boehringer Ingelheim Vetmedica GmbH Prrsv replicon
ES2388909T3 (es) 1999-04-22 2012-10-19 The United States Of America, As Represented Bythe Secretary Of Agriculture Vacuna contra el virus del síndrome respiratorio y reproductivo porcino basada en aislado JA-142 aislada
SG153829A1 (en) 2004-06-18 2009-07-29 Univ Minnesota Identifying virally infected and vaccinated organisms
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
PT2369001T (pt) 2005-06-24 2016-10-25 Univ Minnesota Vírus srrp, clones infecciosos, os seus mutantes e processos de utilização
US8436337B2 (en) 2009-05-12 2013-05-07 The State of Oregon Acting By and Through The State Board of Higher Education on Behalf of Oregon State Unitiversity Amorphous multi-component metallic thin films for electronic devices
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
EP2675475B1 (en) 2011-02-17 2015-07-01 Boehringer Ingelheim Vetmedica GmbH Novel european prrsv strain
SG192821A1 (en) 2011-02-17 2013-09-30 Boehringer Ingelheim Vetmed Commercial scale process for production of prrsv
US20140302310A1 (en) * 2011-03-18 2014-10-09 The State of Oregon Acting by and Through the State Board of Higher Education on Behalf of Or... Amorphous multi-component metal/metal oxide nanolaminate metamaterials and devices based thereon
JP6101251B2 (ja) 2011-05-07 2017-03-22 ラボラトリオ アヴィメキシコ エスエー ディーイー シーヴィーLaboratorio Avi−Mex, S.A. De C.V. ウイルスベクターにおける抗ｐｒｒｓ組換えワクチン
US9187731B2 (en) * 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
EP2737059A1 (en) 2011-07-29 2014-06-04 Boehringer Ingelheim Vetmedica GmbH Novel prrs virus inducing type i interferon in susceptible cells
US9099230B2 (en) 2012-11-12 2015-08-04 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State Univesity Amorphous metal thin-film non-linear resistor
US9579373B2 (en) 2013-03-15 2017-02-28 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
DK3591042T5 (da) 2013-12-20 2024-09-02 Boehringer Ingelheim Vetmedica Gmbh PRRS-virusvariant, cDNA-klon af europæisk PRRS-virus samt anvendelser deraf

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6773908B1 (en) * 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6592873B1 (en) * 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US20020012670A1 (en) * 2000-01-26 2002-01-31 Knut Elbers Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
US6841364B2 (en) * 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof

Also Published As

Publication number Publication date
WO2006002193A3 (en) 2006-03-02
MXPA06014821A (es) 2007-03-26
EP1755664B1 (en) 2015-06-10
KR20070028431A (ko) 2007-03-12
AR049825A1 (es) 2006-09-06
ES2546933T3 (es) 2015-09-30
WO2006002193A2 (en) 2006-01-05
AU2005258092A1 (en) 2006-01-05
CA2570778A1 (en) 2006-01-05
JP2008503221A (ja) 2008-02-07
DK1755664T3 (en) 2015-08-24
BRPI0510930A (pt) 2007-11-20
US7722878B2 (en) 2010-05-25
EP1755664A2 (en) 2007-02-28
TW200603825A (en) 2006-02-01
US20080038293A1 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
RU2007101531A (ru) Субъединичная вакцина против prrsv
Lipskaya et al. Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine‐associated polio cases
Mougou et al. New insights into the identity and origin of the causal agent of oak powdery mildew in Europe
WO2005030800A3 (en) Oligonucleotide analog and method for treating flavivirus infections
JP2008503221A5 (enExample)
Nagai et al. Nucleotide sequence homology to bovine viral diarrhea virus 2 (BVDV 2) in the 5′ untranslated region of BVDVs from cattle with mucosal disease or persistent infection in Japan
JP2005511076A5 (enExample)
JP2002542827A5 (enExample)
YU37502A (sh) Infektivni klonovi
Bochkov et al. Phylogenetic analysis of partial S1 and N gene sequences of infectious bronchitis virus isolates from Italy revealed genetic diversity and recombination
CN108251384B (zh) 一株鱼类弹状病毒弱毒疫苗株
RU96112197A (ru) Гены рецептора трансферрина haemophilus
Graff et al. Mutational events in consecutive passages of hepatitis A virus strain GBM during cell culture adaptation
Breard et al. Molecular epidemiology of bluetongue virus serotype 4 isolated in the Mediterranean Basin between 1979 and 2004
Odemuyiwa et al. An outbreak of African swine fever in Nigeria: virus isolation and molecular characterization of the VP72 gene of a first isolate from West Africa
CN105816871A (zh) 一种中国虹鳟传染性造血器官坏死病核酸疫苗及其应用
RU2018130683A (ru) Аттенуированный вирус инфекционного бронхита
Flaisz et al. Babesia genotypes in Haemaphysalis concinna collected from birds in Hungary reflect phylogeographic connections with Siberia and the Far East
Giangaspero et al. Genoepidemiological evaluation of Bovine viral diarrhea virus 2 species based on secondary structures in the 5'untranslated region
Literák et al. Restriction fragment length polymorphism and virulence of Czech Toxoplasma gondii strains
Samuel et al. Serological and biochemical analysis of some recent type A foot-and-mouth disease virus isolates from the Middle East
RU2010125695A (ru) Гены, кодирующие главный капсидный белок l1 вируса папилломы человека, и их применение
Ito et al. The determination of the partial 18 S ribosomal DNA sequences of Cordyceps species
López-Flores et al. Characterization of actin genes in Bonamia ostreae and their application to phylogeny of the Haplosporidia
Hemadri et al. Genetic analysis of foot-and-mouth disease virus type O isolates responsible for field outbreaks in India between 1993 and 1999